Three-stage contingent screening for Down syndrome

Prenatal Diagnosis

Volumn 26, Issue 6, 2006, Pages 528-534

  Wright, Dave ^a   Bradbury, Ian ^b   Cuckle, Howard ^c   Gardosi, Jason ^d   Tonks, Ann ^d   Standing, Sue ^e   Benn, Peter ^f  

^a UNIVERSITY OF PLYMOUTH   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d Perinatal Institute   (United Kingdom)

^e BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^f UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Down syndrome; Modelling; Policy; Prenatal screening; Sequential

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL; INHIBIN A; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ARTICLE; CHEMICAL ANALYSIS; CONTINGENT VALUATION; CONTROLLED STUDY; DOWN SYNDROME; FIRST TRIMESTER PREGNANCY; HUMAN; MONTE CARLO METHOD; NORMAL DISTRIBUTION; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PRIORITY JOURNAL; SCREENING; SECOND TRIMESTER PREGNANCY;

ALGORITHMS; BIOLOGICAL MARKERS; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MATERNAL AGE; MULTIPHASIC SCREENING; NUCHAL TRANSLUCENCY MEASUREMENT; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS;

EID: 33745605228     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1451     Document Type: Article

References (16)

1. Benn P, Wright D, Cuckle H. 2005. Practical strategies in contingent sequential screening for Down's syndrome. Prenat Diagn 25: 645-652. DOI: 10.1111/j.1471-0528.2005.00560.x.
2. Christiansen M, Larsen SO. 2002. An increase in cost-effectiveness of first trimester maternal screening programmes for fetal chromosome anomalies is obtained by contingent testing. Prenat Diagn 22: 482-486.
3. Cuckle H, Arbuzova S. 2002. The efficiency and clinical practicality of multi-modality screening strategies. In Early Prenatal Diagnosis, Fetal Cells and DNA in the Mother: Proceedings of the 12th Fetal Cell Workshop, Macek M, Bianchi D, Cuckle H (eds). Charles University Press: Prague: 387-397.
4. Cuckle H, Arbuzova S. 2004. Multianalyte Maternal serum screening for chromosomal defects. In Genetic Disorders and the Fetus: Diagnosis, Prevention and Treatment (5th edn) Milunsky Aubrey (ed.). Johns Hopkins University Press: Baltimore.
5. Cuckle H, Benn P, Wright D. 2005. Down syndrome screening in the first and/or second trimester: model predicted performance using meta-analysis parameters. Semin Neonatol 29: 252-257.
6. Maymon R, Betser M, Dreazen E, Padoa A, Herman A. 2004. A model for disclosing the first trimester part of an integrated Down's syndrome screening test. Clin Genet 65: 113-119.
7. Maymon R, Cuckle H, Jones R, Reish O, Herman A. 2005. Predicting the result of additional second trimester markers from a woman's first trimester marker profile: a new concept in Down's syndrome screening. Prenat Diagn 25: 1102-1106.
8. Larsen SO, Christiansen M, Norgaard-Pedersen B. 2005. Which contingent sequential screening protocol? (Letter). Prenat Diagn 25: 1168-1169.
9. National Center for Health Statistics. 2004. Vital Statistics of the United States. 2002. Natality Data Set. CD ROM, Series 21: Hyattsville, MD; 16.
10. Office of National Statistics. 2002. Birth Statistics, Series FM1, The Stationary Office: London; vol 30.
11. Wald N, Watt HC, Hackshaw AK. 1999. Integrated screening for Down syndrome based on tests performed during the first and second trimesters. N Engl J Med 341: 461-467.
12. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. 2003. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen 10(2): 56-104.
13. Wald N, Rodeck C, Rudnicka A, Hackshaw A. 2004. Nuchal translucency and gestational age. Prenat Diagn 24(2): 150-151.
14. Wright DE, Bray I. 2000. Estimating birth prevalence of Down's syndrome. J Epidemiol Biostat 5(2): 89-97.
15. Wright D, Bradbury I, Benn P, Cuckle H, Ritchie K. 2004. Contingent screening for Down's syndrome is an efficient alternative to non-disclosure sequential screening. Prenat Diagn 24: 762-766.
16. Wright D, Bradbury I, Benn P, Cuckle H, Ritchie K. 2005. Which contingent sequential screening strategy (Letter). Prenat Diagn 25: 520-521.